Share Price and Basic Stock Data
Last Updated: October 28, 2025, 12:17 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Daikaffil Chemicals India Ltd, operating in the Dyes & Pigments industry, has faced substantial challenges in recent years, as evidenced by its revenue trajectory. The company reported sales of ₹1.30 Cr in March 2022, which significantly dwindled to ₹0.64 Cr by March 2023. Following this, sales have declined to zero from March 2023 through September 2023, highlighting a severe downturn. However, there is a tentative recovery expected, with projected sales of ₹7.50 Cr for March 2025. The drop in sales aligns with a broader industry trend, where companies have faced pressures from fluctuating demand and competition. The operating profit margin (OPM) also reflects this turmoil, standing at -10.25% for the most recent period, indicating that Daikaffil has struggled to manage its costs effectively against its declining revenue. Despite this, the company has reported a recovery in net profit to ₹-1.59 Cr for March 2025, suggesting a potential stabilization in operations, albeit still in the negative territory.
Profitability and Efficiency Metrics
Daikaffil’s profitability metrics reveal significant challenges, with a reported net profit of ₹-1.59 Cr for March 2025 and an EPS of ₹-2.65 for the same period. The company’s return on equity (ROE) and return on capital employed (ROCE) stood at 18.6%, indicating that while the company has the potential to generate returns on its equity and capital, its operational efficiency remains questionable given the negative profitability figures. The interest coverage ratio is notably strong at 188.00x, suggesting that the company can comfortably meet its interest obligations, despite the absence of borrowings. However, the cash conversion cycle of 215.26 days signals inefficiencies in converting investments into cash flow, which could hinder liquidity. The operating profit margin has remained negative, particularly severe at -298.44% in March 2023, underscoring the struggle to maintain profitability amidst rising operational costs and reduced sales.
Balance Sheet Strength and Financial Ratios
Daikaffil Chemicals showcases a relatively strong balance sheet with no reported borrowings, reflecting a debt-free status that could be advantageous during challenging economic conditions. As of March 2025, the company’s reserves stood at ₹2.85 Cr, indicating a decline from ₹16.12 Cr in March 2023, which raises concerns about financial stability and ability to weather future downturns. The total liabilities amounted to ₹14.78 Cr, alongside total assets of ₹14.78 Cr, resulting in a balanced sheet with a debt-to-equity ratio of 0.00, which is favorable compared to many industry peers. The company’s current ratio is not available, but the absence of debt provides a cushion for liquidity. The price-to-book value (P/BV) ratio of 1.34x is slightly above the sector norm, which typically ranges from 1.0 to 1.2 for companies in this industry. This suggests that investors are willing to pay a premium for Daikaffil’s stock, although the underlying financial performance raises questions about sustainability.
Shareholding Pattern and Investor Confidence
The shareholding structure of Daikaffil Chemicals indicates a significant presence of promoters, who hold 52.64% of the company as of March 2025. This majority stake reflects strong control by the founding members, potentially instilling confidence among retail investors regarding the company’s governance. However, the lack of Foreign Institutional Investors (FIIs) and negligible Domestic Institutional Investors (DIIs) indicates a cautious stance from institutional investors, which may reflect concerns over the company’s financial health and operational performance. The public shareholding decreased to 47.35%, suggesting a possible exit by retail investors amid the company’s operational struggles. The total number of shareholders has also declined to 3,145, indicating a waning interest in the stock. This trend could affect liquidity and market perception, as a shrinking shareholder base may lead to increased volatility in the stock price.
Outlook, Risks, and Final Insight
If margins sustain and Daikaffil Chemicals can successfully navigate operational challenges, including improving sales and managing costs, the company may experience a turnaround in its financial performance. The current debt-free status is a considerable strength, providing flexibility to invest in growth initiatives or weather economic downturns. However, risks remain prevalent, particularly the reliance on a single segment (Dyes & Pigments) and the potential for continued volatility in demand. Additionally, the company’s ability to convert its inventory and receivables into cash efficiently will be critical to enhancing liquidity. If the company can leverage its strong interest coverage ratio and stabilize its sales, it may regain investor confidence and improve its market position. The upcoming periods will be crucial in determining whether Daikaffil can rebound from its current challenges and return to profitability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Daikaffil Chemicals India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dynamic Industries Ltd | 54.2 Cr. | 179 | 190/68.5 | 28.4 | 159 | 0.56 % | 5.68 % | 3.39 % | 10.0 |
| Daikaffil Chemicals India Ltd | 72.6 Cr. | 121 | 281/108 | 14.8 | 0.00 % | 18.6 % | 18.6 % | 10.0 | |
| Amal Ltd | 898 Cr. | 726 | 1,148/380 | 23.2 | 91.7 | 0.14 % | 36.3 % | 35.0 % | 10.0 |
| Vidhi Specialty Food Ingredients Ltd | 1,656 Cr. | 332 | 572/331 | 34.6 | 60.5 | 1.49 % | 18.7 % | 14.9 % | 1.00 |
| Ushanti Colour Chem Ltd | 46.4 Cr. | 41.2 | 67.1/38.0 | 39.6 | 0.00 % | 0.98 % | 5.98 % | 10.0 | |
| Industry Average | 1,514.54 Cr | 336.71 | 35.65 | 186.82 | 0.35% | 11.00% | 9.10% | 8.13 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.30 | 0.63 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.50 | 4.00 |
| Expenses | 1.46 | 1.29 | 0.43 | 0.43 | 0.40 | 0.40 | 0.29 | 0.25 | 1.31 | 0.44 | 0.90 | 3.55 | 4.41 |
| Operating Profit | -0.16 | -0.66 | -0.42 | -0.43 | -0.40 | -0.40 | -0.29 | -0.25 | -1.31 | -0.44 | -0.90 | -0.05 | -0.41 |
| OPM % | -12.31% | -104.76% | -4,200.00% | -1.43% | -10.25% | ||||||||
| Other Income | 0.16 | 0.13 | 0.13 | 0.10 | 0.11 | 0.17 | 0.23 | 0.15 | 0.16 | 0.10 | 0.09 | 0.07 | 0.21 |
| Interest | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.28 | 0.30 | 0.18 | 0.18 | 0.55 | 0.23 | 0.22 | 0.22 | -0.32 | 0.07 | 0.06 | 0.06 | 0.08 |
| Profit before tax | -0.29 | -0.84 | -0.47 | -0.51 | -0.84 | -0.46 | -0.28 | -0.32 | -0.83 | -0.41 | -0.87 | -0.04 | -0.28 |
| Tax % | -17.24% | -1.19% | 2.13% | -9.80% | -26.19% | -4.35% | -14.29% | -12.50% | 13.25% | -26.83% | -33.33% | 775.00% | 25.00% |
| Net Profit | -0.25 | -0.84 | -0.48 | -0.47 | -0.62 | -0.43 | -0.24 | -0.28 | -0.95 | -0.30 | -0.58 | -0.36 | -0.35 |
| EPS in Rs | -0.42 | -1.40 | -0.80 | -0.78 | -1.03 | -0.72 | -0.40 | -0.47 | -1.58 | -0.50 | -0.97 | -0.60 | -0.58 |
Last Updated: May 31, 2025, 6:23 am
Below is a detailed analysis of the quarterly data for Daikaffil Chemicals India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.50 Cr. (Dec 2024) to 4.00 Cr., marking an increase of 0.50 Cr..
- For Expenses, as of Mar 2025, the value is 4.41 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.55 Cr. (Dec 2024) to 4.41 Cr., marking an increase of 0.86 Cr..
- For Operating Profit, as of Mar 2025, the value is -0.41 Cr.. The value appears to be declining and may need further review. It has decreased from -0.05 Cr. (Dec 2024) to -0.41 Cr., marking a decrease of 0.36 Cr..
- For OPM %, as of Mar 2025, the value is -10.25%. The value appears to be declining and may need further review. It has decreased from -1.43% (Dec 2024) to -10.25%, marking a decrease of 8.82%.
- For Other Income, as of Mar 2025, the value is 0.21 Cr.. The value appears strong and on an upward trend. It has increased from 0.07 Cr. (Dec 2024) to 0.21 Cr., marking an increase of 0.14 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.08 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.06 Cr. (Dec 2024) to 0.08 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Mar 2025, the value is -0.28 Cr.. The value appears to be declining and may need further review. It has decreased from -0.04 Cr. (Dec 2024) to -0.28 Cr., marking a decrease of 0.24 Cr..
- For Tax %, as of Mar 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 775.00% (Dec 2024) to 25.00%, marking a decrease of 750.00%.
- For Net Profit, as of Mar 2025, the value is -0.35 Cr.. The value appears strong and on an upward trend. It has increased from -0.36 Cr. (Dec 2024) to -0.35 Cr., marking an increase of 0.01 Cr..
- For EPS in Rs, as of Mar 2025, the value is -0.58. The value appears strong and on an upward trend. It has increased from -0.60 (Dec 2024) to -0.58, marking an increase of 0.02.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:33 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 33.28 | 34.35 | 27.41 | 26.44 | 22.82 | 16.84 | 15.72 | 11.40 | 8.16 | 0.64 | 0.00 | 7.50 | 11.38 |
| Expenses | 30.31 | 31.36 | 24.24 | 21.77 | 19.53 | 15.04 | 13.88 | 11.23 | 10.20 | 2.55 | 2.25 | 9.29 | 12.22 |
| Operating Profit | 2.97 | 2.99 | 3.17 | 4.67 | 3.29 | 1.80 | 1.84 | 0.17 | -2.04 | -1.91 | -2.25 | -1.79 | -0.84 |
| OPM % | 8.92% | 8.70% | 11.57% | 17.66% | 14.42% | 10.69% | 11.70% | 1.49% | -25.00% | -298.44% | -23.87% | -7.38% | |
| Other Income | 0.29 | -0.16 | 0.55 | 0.55 | 0.85 | 0.42 | 0.85 | 0.55 | 0.47 | 0.47 | 0.71 | 0.47 | 0.38 |
| Interest | 0.36 | 0.26 | 0.14 | 0.07 | 0.05 | 0.03 | 0.07 | 0.05 | 0.03 | 0.01 | 0.00 | 0.01 | 0.01 |
| Depreciation | 0.61 | 0.42 | 0.40 | 1.48 | 0.97 | 0.96 | 1.12 | 1.12 | 1.13 | 1.21 | 0.35 | 0.27 | 0.30 |
| Profit before tax | 2.29 | 2.15 | 3.18 | 3.67 | 3.12 | 1.23 | 1.50 | -0.45 | -2.73 | -2.66 | -1.89 | -1.60 | -0.77 |
| Tax % | 37.55% | 27.91% | 33.96% | 33.51% | 23.40% | 29.27% | 28.00% | -11.11% | -8.42% | -9.77% | 0.53% | -0.62% | |
| Net Profit | 1.44 | 1.55 | 2.10 | 2.44 | 2.40 | 0.86 | 1.08 | -0.41 | -2.50 | -2.41 | -1.90 | -1.59 | -0.87 |
| EPS in Rs | 2.40 | 2.58 | 3.50 | 4.07 | 4.00 | 1.43 | 1.80 | -0.68 | -4.17 | -4.02 | -3.17 | -2.65 | -1.45 |
| Dividend Payout % | 33.33% | 30.97% | 28.57% | 41.80% | 30.00% | 0.00% | 38.89% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 7.64% | 35.48% | 16.19% | -1.64% | -64.17% | 25.58% | -137.96% | -509.76% | 3.60% | 21.16% | 16.32% |
| Change in YoY Net Profit Growth (%) | 0.00% | 27.84% | -19.29% | -17.83% | -62.53% | 89.75% | -163.54% | -371.79% | 513.36% | 17.56% | -4.85% |
Daikaffil Chemicals India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -14% |
| 5 Years: | -14% |
| 3 Years: | -3% |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 9% |
| TTM: | 51% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 39% |
| 3 Years: | 90% |
| 1 Year: | -3% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -9% |
| 3 Years: | -13% |
| Last Year: | -19% |
Last Updated: September 5, 2025, 3:06 pm
Balance Sheet
Last Updated: September 10, 2025, 3:27 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
| Reserves | 4.43 | 5.22 | 6.60 | 18.38 | 19.54 | 19.46 | 19.96 | 19.58 | 18.52 | 16.12 | 4.54 | 2.85 |
| Borrowings | 2.37 | 1.89 | 0.71 | 0.00 | 0.00 | 0.00 | 0.71 | 0.56 | 0.37 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 9.38 | 6.83 | 5.56 | 3.35 | 4.72 | 2.64 | 3.54 | 2.36 | 1.81 | 1.35 | 1.61 | 5.93 |
| Total Liabilities | 22.18 | 19.94 | 18.87 | 27.73 | 30.26 | 28.10 | 30.21 | 28.50 | 26.70 | 23.47 | 12.15 | 14.78 |
| Fixed Assets | 5.51 | 5.37 | 5.34 | 15.14 | 14.69 | 14.16 | 14.01 | 12.98 | 13.92 | 12.43 | 1.63 | 1.96 |
| CWIP | 0.00 | 0.00 | 0.04 | 0.09 | 0.01 | 0.02 | 0.04 | 0.03 | 0.05 | 0.05 | 0.05 | 0.32 |
| Investments | 0.06 | 0.10 | 0.25 | 0.28 | 2.27 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 | 0.19 |
| Other Assets | 16.61 | 14.47 | 13.24 | 12.22 | 13.29 | 13.73 | 15.97 | 15.30 | 12.54 | 10.80 | 10.28 | 12.31 |
| Total Assets | 22.18 | 19.94 | 18.87 | 27.73 | 30.26 | 28.10 | 30.21 | 28.50 | 26.70 | 23.47 | 12.15 | 14.78 |
Below is a detailed analysis of the balance sheet data for Daikaffil Chemicals India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
- For Reserves, as of Mar 2025, the value is 2.85 Cr.. The value appears to be declining and may need further review. It has decreased from 4.54 Cr. (Mar 2024) to 2.85 Cr., marking a decrease of 1.69 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 5.93 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.61 Cr. (Mar 2024) to 5.93 Cr., marking an increase of 4.32 Cr..
- For Total Liabilities, as of Mar 2025, the value is 14.78 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.15 Cr. (Mar 2024) to 14.78 Cr., marking an increase of 2.63 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1.96 Cr.. The value appears strong and on an upward trend. It has increased from 1.63 Cr. (Mar 2024) to 1.96 Cr., marking an increase of 0.33 Cr..
- For CWIP, as of Mar 2025, the value is 0.32 Cr.. The value appears strong and on an upward trend. It has increased from 0.05 Cr. (Mar 2024) to 0.32 Cr., marking an increase of 0.27 Cr..
- For Investments, as of Mar 2025, the value is 0.19 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.19 Cr..
- For Other Assets, as of Mar 2025, the value is 12.31 Cr.. The value appears strong and on an upward trend. It has increased from 10.28 Cr. (Mar 2024) to 12.31 Cr., marking an increase of 2.03 Cr..
- For Total Assets, as of Mar 2025, the value is 14.78 Cr.. The value appears strong and on an upward trend. It has increased from 12.15 Cr. (Mar 2024) to 14.78 Cr., marking an increase of 2.63 Cr..
Notably, the Reserves (2.85 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.60 | 1.10 | 2.46 | 4.67 | 3.29 | 1.80 | 1.13 | -0.39 | -2.41 | -1.91 | -2.25 | -1.79 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 93.22 | 72.36 | 93.48 | 40.03 | 74.22 | 60.26 | 45.04 | 28.82 | 6.26 | 0.00 | 294.92 | |
| Inventory Days | 93.77 | 70.49 | 81.93 | 82.17 | 84.50 | 122.29 | 133.94 | 154.33 | 124.16 | 1,116.90 | 261.44 | |
| Days Payable | 132.45 | 85.28 | 69.49 | 34.20 | 80.69 | 39.27 | 80.53 | 59.90 | 7.49 | 21.90 | 341.10 | |
| Cash Conversion Cycle | 54.55 | 57.57 | 105.91 | 88.00 | 78.03 | 143.28 | 98.46 | 123.24 | 122.94 | 1,095.00 | 215.26 | |
| Working Capital Days | 46.17 | 47.71 | 83.63 | 76.89 | 93.25 | 113.14 | 73.37 | 99.89 | 108.25 | 4,956.02 | 279.35 | |
| ROCE % | 21.18% | 18.76% | 25.06% | 19.85% | 12.70% | 4.94% | 5.99% | -1.51% | -10.58% | -11.27% | -12.19% | -18.57% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 18 | Mar 17 | Mar 16 | Mar 15 | Mar 14 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.99 | 3.94 | 3.51 | 2.58 | 0.00 |
| Diluted EPS (Rs.) | 3.99 | 3.94 | 3.51 | 2.58 | 0.00 |
| Cash EPS (Rs.) | 5.56 | 6.55 | 4.18 | 3.26 | 0.00 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 42.84 | 40.92 | 20.89 | 18.57 | 0.00 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 42.84 | 40.92 | 21.30 | 18.99 | 0.00 |
| Revenue From Operations / Share (Rs.) | 38.02 | 44.06 | 45.74 | 57.54 | 0.00 |
| PBDIT / Share (Rs.) | 6.81 | 8.64 | 6.13 | 4.65 | 0.00 |
| PBIT / Share (Rs.) | 5.20 | 6.17 | 5.47 | 3.96 | 0.00 |
| PBT / Share (Rs.) | 5.17 | 6.14 | 5.31 | 3.61 | 0.00 |
| Net Profit / Share (Rs.) | 3.95 | 4.08 | 3.52 | 2.57 | 0.00 |
| NP After MI And SOA / Share (Rs.) | 3.99 | 4.07 | 3.51 | 2.58 | 0.00 |
| PBDIT Margin (%) | 17.91 | 19.61 | 13.41 | 8.08 | 9.24 |
| PBIT Margin (%) | 13.68 | 14.01 | 11.96 | 6.87 | 7.44 |
| PBT Margin (%) | 13.58 | 13.92 | 11.61 | 6.27 | 6.54 |
| Net Profit Margin (%) | 10.39 | 9.26 | 7.69 | 4.46 | 4.02 |
| NP After MI And SOA Margin (%) | 10.48 | 9.24 | 7.66 | 4.49 | 4.21 |
| Return on Networth / Equity (%) | 9.37 | 10.02 | 17.03 | 14.13 | 0.00 |
| Return on Capital Employeed (%) | 11.66 | 14.30 | 24.61 | 20.13 | 0.00 |
| Return On Assets (%) | 7.86 | 8.76 | 11.04 | 7.69 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.05 | 0.17 | 0.00 |
| Asset Turnover Ratio (%) | 0.78 | 1.13 | 1.41 | 0.00 | 0.00 |
| Current Ratio (X) | 3.64 | 6.15 | 2.33 | 1.75 | 0.00 |
| Quick Ratio (X) | 2.79 | 4.42 | 1.63 | 1.22 | 0.00 |
| Inventory Turnover Ratio (X) | 4.00 | 3.91 | 3.90 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 51.29 | 29.57 | 28.51 | 30.94 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 36.54 | 18.41 | 23.98 | 24.38 | 0.00 |
| Earning Retention Ratio (%) | 48.71 | 70.43 | 71.49 | 69.06 | 0.00 |
| Cash Earning Retention Ratio (%) | 63.46 | 81.59 | 76.02 | 75.62 | 0.00 |
| Interest Coverage Ratio (X) | 188.00 | 227.77 | 38.19 | 13.38 | 8.22 |
| Interest Coverage Ratio (Post Tax) (X) | 110.03 | 108.62 | 22.92 | 8.48 | 5.44 |
| Enterprise Value (Cr.) | 30.57 | 33.78 | 15.30 | 14.48 | 0.00 |
| EV / Net Operating Revenue (X) | 1.34 | 1.28 | 0.55 | 0.41 | 0.00 |
| EV / EBITDA (X) | 7.48 | 6.51 | 4.16 | 5.18 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 1.50 | 1.45 | 0.57 | 0.40 | 0.00 |
| Retention Ratios (%) | 48.70 | 70.42 | 71.48 | 69.05 | 0.00 |
| Price / BV (X) | 1.34 | 1.57 | 1.27 | 1.29 | 0.00 |
| Price / Net Operating Revenue (X) | 1.50 | 1.45 | 0.57 | 0.40 | 0.00 |
| EarningsYield | 0.07 | 0.06 | 0.13 | 0.10 | 0.00 |
After reviewing the key financial ratios for Daikaffil Chemicals India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 18, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 18, the value is 3.99. This value is below the healthy minimum of 5. It has increased from 3.94 (Mar 17) to 3.99, marking an increase of 0.05.
- For Diluted EPS (Rs.), as of Mar 18, the value is 3.99. This value is below the healthy minimum of 5. It has increased from 3.94 (Mar 17) to 3.99, marking an increase of 0.05.
- For Cash EPS (Rs.), as of Mar 18, the value is 5.56. This value is within the healthy range. It has decreased from 6.55 (Mar 17) to 5.56, marking a decrease of 0.99.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 42.84. It has increased from 40.92 (Mar 17) to 42.84, marking an increase of 1.92.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 18, the value is 42.84. It has increased from 40.92 (Mar 17) to 42.84, marking an increase of 1.92.
- For Revenue From Operations / Share (Rs.), as of Mar 18, the value is 38.02. It has decreased from 44.06 (Mar 17) to 38.02, marking a decrease of 6.04.
- For PBDIT / Share (Rs.), as of Mar 18, the value is 6.81. This value is within the healthy range. It has decreased from 8.64 (Mar 17) to 6.81, marking a decrease of 1.83.
- For PBIT / Share (Rs.), as of Mar 18, the value is 5.20. This value is within the healthy range. It has decreased from 6.17 (Mar 17) to 5.20, marking a decrease of 0.97.
- For PBT / Share (Rs.), as of Mar 18, the value is 5.17. This value is within the healthy range. It has decreased from 6.14 (Mar 17) to 5.17, marking a decrease of 0.97.
- For Net Profit / Share (Rs.), as of Mar 18, the value is 3.95. This value is within the healthy range. It has decreased from 4.08 (Mar 17) to 3.95, marking a decrease of 0.13.
- For NP After MI And SOA / Share (Rs.), as of Mar 18, the value is 3.99. This value is within the healthy range. It has decreased from 4.07 (Mar 17) to 3.99, marking a decrease of 0.08.
- For PBDIT Margin (%), as of Mar 18, the value is 17.91. This value is within the healthy range. It has decreased from 19.61 (Mar 17) to 17.91, marking a decrease of 1.70.
- For PBIT Margin (%), as of Mar 18, the value is 13.68. This value is within the healthy range. It has decreased from 14.01 (Mar 17) to 13.68, marking a decrease of 0.33.
- For PBT Margin (%), as of Mar 18, the value is 13.58. This value is within the healthy range. It has decreased from 13.92 (Mar 17) to 13.58, marking a decrease of 0.34.
- For Net Profit Margin (%), as of Mar 18, the value is 10.39. This value exceeds the healthy maximum of 10. It has increased from 9.26 (Mar 17) to 10.39, marking an increase of 1.13.
- For NP After MI And SOA Margin (%), as of Mar 18, the value is 10.48. This value is within the healthy range. It has increased from 9.24 (Mar 17) to 10.48, marking an increase of 1.24.
- For Return on Networth / Equity (%), as of Mar 18, the value is 9.37. This value is below the healthy minimum of 15. It has decreased from 10.02 (Mar 17) to 9.37, marking a decrease of 0.65.
- For Return on Capital Employeed (%), as of Mar 18, the value is 11.66. This value is within the healthy range. It has decreased from 14.30 (Mar 17) to 11.66, marking a decrease of 2.64.
- For Return On Assets (%), as of Mar 18, the value is 7.86. This value is within the healthy range. It has decreased from 8.76 (Mar 17) to 7.86, marking a decrease of 0.90.
- For Total Debt / Equity (X), as of Mar 18, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 17) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 18, the value is 0.78. It has decreased from 1.13 (Mar 17) to 0.78, marking a decrease of 0.35.
- For Current Ratio (X), as of Mar 18, the value is 3.64. This value exceeds the healthy maximum of 3. It has decreased from 6.15 (Mar 17) to 3.64, marking a decrease of 2.51.
- For Quick Ratio (X), as of Mar 18, the value is 2.79. This value exceeds the healthy maximum of 2. It has decreased from 4.42 (Mar 17) to 2.79, marking a decrease of 1.63.
- For Inventory Turnover Ratio (X), as of Mar 18, the value is 4.00. This value is within the healthy range. It has increased from 3.91 (Mar 17) to 4.00, marking an increase of 0.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 18, the value is 51.29. This value exceeds the healthy maximum of 50. It has increased from 29.57 (Mar 17) to 51.29, marking an increase of 21.72.
- For Dividend Payout Ratio (CP) (%), as of Mar 18, the value is 36.54. This value is within the healthy range. It has increased from 18.41 (Mar 17) to 36.54, marking an increase of 18.13.
- For Earning Retention Ratio (%), as of Mar 18, the value is 48.71. This value is within the healthy range. It has decreased from 70.43 (Mar 17) to 48.71, marking a decrease of 21.72.
- For Cash Earning Retention Ratio (%), as of Mar 18, the value is 63.46. This value is within the healthy range. It has decreased from 81.59 (Mar 17) to 63.46, marking a decrease of 18.13.
- For Interest Coverage Ratio (X), as of Mar 18, the value is 188.00. This value is within the healthy range. It has decreased from 227.77 (Mar 17) to 188.00, marking a decrease of 39.77.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 18, the value is 110.03. This value is within the healthy range. It has increased from 108.62 (Mar 17) to 110.03, marking an increase of 1.41.
- For Enterprise Value (Cr.), as of Mar 18, the value is 30.57. It has decreased from 33.78 (Mar 17) to 30.57, marking a decrease of 3.21.
- For EV / Net Operating Revenue (X), as of Mar 18, the value is 1.34. This value is within the healthy range. It has increased from 1.28 (Mar 17) to 1.34, marking an increase of 0.06.
- For EV / EBITDA (X), as of Mar 18, the value is 7.48. This value is within the healthy range. It has increased from 6.51 (Mar 17) to 7.48, marking an increase of 0.97.
- For MarketCap / Net Operating Revenue (X), as of Mar 18, the value is 1.50. This value is within the healthy range. It has increased from 1.45 (Mar 17) to 1.50, marking an increase of 0.05.
- For Retention Ratios (%), as of Mar 18, the value is 48.70. This value is within the healthy range. It has decreased from 70.42 (Mar 17) to 48.70, marking a decrease of 21.72.
- For Price / BV (X), as of Mar 18, the value is 1.34. This value is within the healthy range. It has decreased from 1.57 (Mar 17) to 1.34, marking a decrease of 0.23.
- For Price / Net Operating Revenue (X), as of Mar 18, the value is 1.50. This value is within the healthy range. It has increased from 1.45 (Mar 17) to 1.50, marking an increase of 0.05.
- For EarningsYield, as of Mar 18, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 17) to 0.07, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Daikaffil Chemicals India Ltd:
- Net Profit Margin: 10.39%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.66% (Industry Average ROCE: 11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.37% (Industry Average ROE: 9.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 110.03
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.79
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 35.65)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.39%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | Plot No. E/4, M.I.D.C, Tarapur, Palghar District Maharashtra 401506 | cs@daikaffil.com http://www.daikaffil.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sadashiv K Shetty | Chairman |
| Mr. Raghuram K Shetty | Managing Director |
| Mr. Omprakash Singh | Independent Director |
| Mrs. Bhagavati Kalpesh Donga | Independent Director |
FAQ
What is the intrinsic value of Daikaffil Chemicals India Ltd?
Daikaffil Chemicals India Ltd's intrinsic value (as of 28 October 2025) is 33.69 which is 72.16% lower the current market price of 121.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 72.6 Cr. market cap, FY2025-2026 high/low of 281/108, reserves of ₹2.85 Cr, and liabilities of 14.78 Cr.
What is the Market Cap of Daikaffil Chemicals India Ltd?
The Market Cap of Daikaffil Chemicals India Ltd is 72.6 Cr..
What is the current Stock Price of Daikaffil Chemicals India Ltd as on 28 October 2025?
The current stock price of Daikaffil Chemicals India Ltd as on 28 October 2025 is 121.
What is the High / Low of Daikaffil Chemicals India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Daikaffil Chemicals India Ltd stocks is 281/108.
What is the Stock P/E of Daikaffil Chemicals India Ltd?
The Stock P/E of Daikaffil Chemicals India Ltd is .
What is the Book Value of Daikaffil Chemicals India Ltd?
The Book Value of Daikaffil Chemicals India Ltd is 14.8.
What is the Dividend Yield of Daikaffil Chemicals India Ltd?
The Dividend Yield of Daikaffil Chemicals India Ltd is 0.00 %.
What is the ROCE of Daikaffil Chemicals India Ltd?
The ROCE of Daikaffil Chemicals India Ltd is 18.6 %.
What is the ROE of Daikaffil Chemicals India Ltd?
The ROE of Daikaffil Chemicals India Ltd is 18.6 %.
What is the Face Value of Daikaffil Chemicals India Ltd?
The Face Value of Daikaffil Chemicals India Ltd is 10.0.